Northwest Biotherapeutics Acquires Advent BioServices (DCVax Manufacturing Scale-Up)
October 26, 2025
Northwest Biotherapeutics (NWBio) has completed its acquisition of Advent BioServices Ltd., with Advent becoming a wholly owned subsidiary. The deal is intended to create a more integrated manufacturing and operations platform to scale production of NWBio’s DCVax immunotherapy products, including facilitating consolidation of facilities and reallocation of resources to Sawston and capacity expansion in the United States.
- Buyers
- Northwest Biotherapeutics, Inc. (NWBio)
- Targets
- Advent BioServices Ltd.
- Sellers
- Toucan Holdings LLC
- Platforms
- Industry
- Biotechnology
- Location
- United Kingdom
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.